Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

Schizophrenia-related dysbindin-1 gene is required for innate immune response and homeostasis in the developing subventricular zone.

Al-Shammari AR, Bhardwaj SK, Musaelyan K, Srivastava LK, Szele FG.

NPJ Schizophr. 2018 Jul 23;4(1):15. doi: 10.1038/s41537-018-0057-5.

2.

The role of PANSS symptoms and adverse events in explaining the effects of paliperidone on social functioning: a causal mediation analysis approach.

Zou X, Zhu Y, Jackson JW, Bellavia A, Fitzmaurice GM, Centorrino F, Valeri L.

NPJ Schizophr. 2018 Jun 27;4(1):13. doi: 10.1038/s41537-018-0054-8.

3.

Risk of weight gain for specific antipsychotic drugs: a meta-analysis.

Spertus J, Horvitz-Lennon M, Abing H, Normand SL.

NPJ Schizophr. 2018 Jun 27;4(1):12. doi: 10.1038/s41537-018-0053-9.

4.

The Open Translational Science in Schizophrenia (OPTICS) project: an open-science project bringing together Janssen clinical trial and NIMH data.

Wilcox MA, Savitz AJ, Addington AM, Gray GS, Guinan EC, Jackson JW, Lehner T, Normand SL, Ranu H, Senthil G, Spertus J, Valeri L, Ross JS.

NPJ Schizophr. 2018 Jun 27;4(1):14. doi: 10.1038/s41537-018-0055-7. Review.

5.

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.

Nelson B, Amminger GP, Yuen HP, Markulev C, Lavoie S, Schäfer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD.

NPJ Schizophr. 2018 Jun 25;4(1):11. doi: 10.1038/s41537-018-0052-x.

6.

Trajectories and changes in individual items of positive and negative syndrome scale among schizophrenia patients prior to impending relapse.

Wang D, Gopal S, Baker S, Narayan VA.

NPJ Schizophr. 2018 Jun 20;4(1):10. doi: 10.1038/s41537-018-0056-6.

7.

Impairment in delay discounting in schizophrenia and schizoaffective disorder but not primary mood disorders.

Brown HE, Hart KL, Snapper LA, Roffman JL, Perlis RH.

NPJ Schizophr. 2018 May 28;4(1):9. doi: 10.1038/s41537-018-0050-z.

8.

Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication.

Cadena EJ, White DM, Kraguljac NV, Reid MA, Lahti AC.

NPJ Schizophr. 2018 May 7;4(1):8. doi: 10.1038/s41537-018-0051-y.

9.

Identification of somatic mutations in monozygotic twins discordant for psychiatric disorders.

Nishioka M, Bundo M, Ueda J, Yoshikawa A, Nishimura F, Sasaki T, Kakiuchi C, Kasai K, Kato T, Iwamoto K.

NPJ Schizophr. 2018 Apr 13;4(1):7. doi: 10.1038/s41537-018-0049-5.

10.

A crossroad for validating digital tools in schizophrenia and mental health.

Torous J, Staples P, Barnett I, Onnela JP, Keshavan M.

NPJ Schizophr. 2018 Apr 6;4(1):6. doi: 10.1038/s41537-018-0048-6. No abstract available.

11.

Altered DNA methylation associated with a translocation linked to major mental illness.

McCartney DL, Walker RM, Morris SW, Anderson SM, Duff BJ, Marioni RE, Millar JK, McCarthy SE, Ryan NM, Lawrie SM, Watson AR, Blackwood DHR, Thomson PA, McIntosh AM, McCombie WR, Porteous DJ, Evans KL.

NPJ Schizophr. 2018 Mar 19;4(1):5. doi: 10.1038/s41537-018-0047-7.

12.
13.

Differential patterns of contextual organization of memory in first-episode psychosis.

Murty VP, McKinney RA, DuBrow S, Jalbrzikowski M, Haas GL, Luna B.

NPJ Schizophr. 2018 Feb 15;4(1):3. doi: 10.1038/s41537-018-0046-8.

14.

Sleep endophenotypes of schizophrenia: slow waves and sleep spindles in unaffected first-degree relatives.

D'Agostino A, Castelnovo A, Cavallotti S, Casetta C, Marcatili M, Gambini O, Canevini M, Tononi G, Riedner B, Ferrarelli F, Sarasso S.

NPJ Schizophr. 2018 Feb 9;4(1):2. doi: 10.1038/s41537-018-0045-9.

15.

The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis.

de Boer J, Prikken M, Lei WU, Begemann M, Sommer I.

NPJ Schizophr. 2018 Jan 10;4(1):1. doi: 10.1038/s41537-017-0043-3. Review.

16.

Characterization of macrophages from schizophrenia patients.

Ormel PR, van Mierlo HC, Litjens M, Strien MEV, Hol EM, Kahn RS, de Witte LD.

NPJ Schizophr. 2017 Nov 14;3(1):41. doi: 10.1038/s41537-017-0042-4.

17.

The association between gene variants and longitudinal structural brain changes in psychosis: a systematic review of longitudinal neuroimaging genetics studies.

Harari JH, Díaz-Caneja CM, Janssen J, Martínez K, Arias B, Arango C.

NPJ Schizophr. 2017 Nov 1;3(1):40. doi: 10.1038/s41537-017-0036-2. Review.

18.

Genetic interaction of DISC1 and Neurexin in the development of fruit fly glutamatergic synapses.

Pandey H, Bourahmoune K, Honda T, Honjo K, Kurita K, Sato T, Sawa A, Furukubo-Tokunaga K.

NPJ Schizophr. 2017 Oct 27;3(1):39. doi: 10.1038/s41537-017-0040-6.

19.

Correspondence regarding two recent publications in npj:schizophrenia about DNAm and accelerated aging in schizophrenia.

Fernandez-Egea E, Kirkpatrick B.

NPJ Schizophr. 2017 Oct 23;3(1):38. doi: 10.1038/s41537-017-0041-5. No abstract available.

20.

A comparison of passive and active estimates of sleep in a cohort with schizophrenia.

Staples P, Torous J, Barnett I, Carlson K, Sandoval L, Keshavan M, Onnela JP.

NPJ Schizophr. 2017 Oct 16;3:37. doi: 10.1038/s41537-017-0038-0. eCollection 2017.

PMID:
29046890

Supplemental Content

Loading ...
Support Center